Full name
ETHIFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,8 | 0,8 | -10,6 |
EBITDA | 1,3 | 1,7 | 1,9 | 7,1 |
Short time liabilities | 1,4 | 1,9 | 2,5 | 29,8 |
Equity capital | 2,6 | 4,9 | 6,2 | 26,3 |
Operating profit (EBIT) | 1 | 1,2 | 1,2 | 1,9 |
Assets | 10,7 | 12 | 12,6 | 4,6 |
Net profit (loss) | 0,8 | 0,8 | 0,8 | -10,6 |
Cash | 0,2 | 0,1 | 0,4 | 224,8 |
Net income from sale | 9,9 | 18,4 | 18,9 | 2,5 |
Liabilities and provisions for liabilities | 8,1 | 7,1 | 6,4 | -10,4 |
Working assets | 5,7 | 7,1 | 7,7 | 8,9 |
Depreciation | 0,3 | 0,5 | 0,6 | 18,2 |
% | % | % | p.p. | |
Profitability of capital | 31,5 | 17,1 | 12,1 | -5 |
Equity capital to total assets | 24,4 | 40,9 | 49,3 | 8,4 |
Gross profit margin | 8,4 | 4,6 | 4 | -0,6 |
EBITDA Margin | 13,6 | 9,4 | 9,9 | 0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 54 | 38 | 48 | 10 |
Current financial liquidity indicator | 1.5944406986236572 | 1.6570791006088257 | 2.130923271179199 | 0,4 |
Net dept to EBITDA | 3.717604637145996 | 2.1847217082977295 | 2.1072096824645996 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane